JP2016539641A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539641A5
JP2016539641A5 JP2016535065A JP2016535065A JP2016539641A5 JP 2016539641 A5 JP2016539641 A5 JP 2016539641A5 JP 2016535065 A JP2016535065 A JP 2016535065A JP 2016535065 A JP2016535065 A JP 2016535065A JP 2016539641 A5 JP2016539641 A5 JP 2016539641A5
Authority
JP
Japan
Prior art keywords
corneal endothelial
endothelial cells
laminin
composition according
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016535065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539641A (ja
JP6470286B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2014/081917 external-priority patent/WO2015080297A1/en
Publication of JP2016539641A publication Critical patent/JP2016539641A/ja
Publication of JP2016539641A5 publication Critical patent/JP2016539641A5/ja
Application granted granted Critical
Publication of JP6470286B2 publication Critical patent/JP6470286B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016535065A 2013-11-27 2014-11-26 ラミニンの角膜内皮細胞培養への応用 Active JP6470286B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013244972 2013-11-27
JP2013244972 2013-11-27
PCT/JP2014/081917 WO2015080297A1 (en) 2013-11-27 2014-11-26 Application of laminin to corneal endothelial cell culture

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019006098A Division JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用

Publications (3)

Publication Number Publication Date
JP2016539641A JP2016539641A (ja) 2016-12-22
JP2016539641A5 true JP2016539641A5 (enExample) 2017-12-07
JP6470286B2 JP6470286B2 (ja) 2019-02-13

Family

ID=52432880

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016535065A Active JP6470286B2 (ja) 2013-11-27 2014-11-26 ラミニンの角膜内皮細胞培養への応用
JP2019006098A Withdrawn JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用
JP2020098407A Pending JP2020188778A (ja) 2013-11-27 2020-06-05 ラミニンの角膜内皮細胞培養への応用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019006098A Withdrawn JP2019054828A (ja) 2013-11-27 2019-01-17 ラミニンの角膜内皮細胞培養への応用
JP2020098407A Pending JP2020188778A (ja) 2013-11-27 2020-06-05 ラミニンの角膜内皮細胞培養への応用

Country Status (10)

Country Link
US (1) US11624053B2 (enExample)
EP (1) EP3074508B1 (enExample)
JP (3) JP6470286B2 (enExample)
CN (1) CN105814195A (enExample)
BR (1) BR112016011096A2 (enExample)
CA (1) CA2931280A1 (enExample)
ES (1) ES2763433T3 (enExample)
MX (1) MX2016006915A (enExample)
RU (1) RU2704984C1 (enExample)
WO (1) WO2015080297A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2788472T3 (pl) 2011-12-06 2019-06-28 Astellas Institute For Regenerative Medicine Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
MX387839B (es) 2014-10-31 2025-03-04 Senju Pharma Co Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea.
JP6849957B2 (ja) * 2015-11-10 2021-03-31 国立大学法人京都大学 ラミニンフラグメント含有培地を用いる細胞培養方法
JP6605618B2 (ja) 2015-11-10 2019-11-20 日機装株式会社 細胞支持複合体および細胞支持複合体の製造方法
WO2018143312A1 (ja) * 2017-01-31 2018-08-09 国立大学法人大阪大学 多能性幹細胞の分化制御方法
US20210372995A1 (en) * 2017-10-22 2021-12-02 The Johns Hopkins University Biomimetic platforms to model vascular pathophysiology, diagnostics, and therapy
WO2019102593A1 (ja) * 2017-11-24 2019-05-31 株式会社Ihi 細胞培養装置
JP6664755B1 (ja) * 2018-10-02 2020-03-13 学校法人同志社 角膜内皮細胞を保存するための方法および容器
WO2020071438A1 (ja) * 2018-10-02 2020-04-09 学校法人同志社 角膜内皮細胞を保存するための方法および容器
US20220133659A1 (en) * 2019-03-12 2022-05-05 Nissan Chemical Corporation Therapeutic agent for corneal diseases
JP2023025311A (ja) * 2020-02-05 2023-02-22 味の素株式会社 タンパク質の製造方法
CN112522179A (zh) * 2020-12-23 2021-03-19 江苏艾尔康生物医药科技有限公司 一种角膜内皮细胞的分离培养方法

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Rho標的タンパク質Rhoキナーゼ
US6153593A (en) 1996-06-05 2000-11-28 The General Hospital Corporation Laminin 5 and the formation of basement membrane structure
FR2765781B1 (fr) 1997-07-08 1999-09-24 Gioia Bruno Di Procede de fabrication d'un accessoire de mode, dispositif pour la mise en oeuvre du procede et accessoire de mode ainsi realise
US6042262A (en) 1997-07-29 2000-03-28 Stryker Technologies Corportion Apparatus for storing, mixing, and dispensing two-component bone cement
US6693169B1 (en) 1998-10-13 2004-02-17 The General Hospital Corporation Laminin 5, 13 and 14 and uses thereof
EP1177290A2 (en) 1999-04-30 2002-02-06 Biostratum, Inc. Recombinant laminin 5
US6635616B2 (en) 2000-05-01 2003-10-21 The General Hospital Corporation Laminin 15
WO2002050111A2 (en) 2000-12-21 2002-06-27 Biostratum, Inc. Isolated laminin 10
PE20020958A1 (es) 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
TWI261055B (en) 2001-03-23 2006-09-01 Bayer Corp Rho-Kinase Inhibitors
CA2443918C (en) 2001-04-11 2012-06-05 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
CA2472619A1 (en) 2002-01-10 2003-07-24 Bayer Corporation Fused pyrimidine derivates as rho-kinase inhibitors
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
CA2483659A1 (en) * 2002-04-30 2003-11-13 Amniotec Inc. Corneal endothelium-like sheet and method of constructing the same
JP2004024852A (ja) 2002-04-30 2004-01-29 Amniotec:Kk 角膜内皮様シート、及びその作製方法
AU2003281623B8 (en) 2002-07-22 2009-06-11 Asahi Kasei Pharma Corporation 5-substituted isoquinoline derivative
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
WO2005039564A1 (en) 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
JP2007507549A (ja) 2003-10-06 2007-03-29 グラクソ グループ リミテッド キナーゼ阻害剤としての1,6,7−三置換アザベンゾイミダゾールの調製
WO2005037197A2 (en) 2003-10-06 2005-04-28 Glaxo Group Limited Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
JP2007507547A (ja) 2003-10-06 2007-03-29 グラクソ グループ リミテッド キナーゼ阻害剤としての1,7−二置換アザベンゾイミダゾールの調製
CN100560142C (zh) * 2003-10-10 2009-11-18 细胞生物工程公司 用于在生物聚合物上培养角膜内皮细胞和相关细胞以及产生人工角膜移植物的方法和组合物
WO2005037144A2 (en) 2003-10-10 2005-04-28 Cellular Bioengineering, Inc. Methods and compositions for growing corneal endothelial and related cells on biopolymers and creation of artifical corneal transplants
KR20070053152A (ko) 2003-10-10 2007-05-23 셀룰라 바이오엔지니어링 인코포레이티드 인간의 각막 내피세포 및 각막세포 이식을 위한 세포배양및 수득방법
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
US7563906B2 (en) 2003-10-15 2009-07-21 Ube Industries, Ltd. Indazole derivatives
EP2438814A3 (en) 2004-01-23 2012-10-03 Advanced Cell Technology, Inc. Improved modalities for the treatment of degenerative diseases of the retina
WO2005087250A1 (en) 2004-02-12 2005-09-22 GOVERNMENT OF THE UNITED STATES OF AMERICA, as respresented by Secretary, Department of Health and Human Services Therapeutic administration of the scrambled anti-angiogenic peptide c16y
EP1720874A4 (en) 2004-02-24 2010-03-03 Bioaxone Therapeutique Inc 4-SUBSTITUTED PIPERIDINE DERIVATIVES
TW200604168A (en) 2004-04-02 2006-02-01 Vertex Pharma Azaindoles useful as inhibitors of rock and other protein kinases
JPWO2006057270A1 (ja) 2004-11-26 2008-06-05 旭化成ファーマ株式会社 含窒素3環化合物
AU2006285915B2 (en) 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
JP5255846B2 (ja) 2006-01-19 2013-08-07 千寿製薬株式会社 生体内で細胞増殖可能な角膜内皮製剤
US20090175835A1 (en) 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
WO2007127172A2 (en) 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8951799B2 (en) 2007-01-04 2015-02-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent stem cells
KR20220151013A (ko) * 2007-08-29 2022-11-11 센주 세이야꾸 가부시키가이샤 각막 내피 세포 접착 촉진제
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
US8680182B2 (en) 2009-06-04 2014-03-25 Clemson University Research Foundation Methods for promoting the revascularization and reenervation of CNS lesions
WO2010140464A1 (ja) 2009-06-05 2010-12-09 国立大学法人 熊本大学 細胞の分化誘導方法
JP5590646B2 (ja) * 2009-10-08 2014-09-17 国立大学法人大阪大学 ヒト多能性幹細胞用培養基材およびその利用
RU2418067C1 (ru) 2009-12-03 2011-05-10 Государственное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" Способ культивирования клеток
WO2011080984A1 (en) 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
MX343462B (es) 2010-12-17 2016-11-07 Biolamina Ab Medio del cultivo celular.
JPWO2012173207A1 (ja) 2011-06-14 2015-02-23 独立行政法人理化学研究所 網膜細胞への分化誘導方法
JP5761827B2 (ja) * 2011-07-15 2015-08-12 国立大学法人大阪大学 角膜内皮細胞の調製方法
JPWO2013047763A1 (ja) 2011-09-29 2015-03-30 オリエンタル酵母工業株式会社 ラミニン511を含んだ系で哺乳類細胞を培養する方法
TW202434266A (zh) 2011-11-14 2024-09-01 安斯泰來再生醫藥協會 人類rpe細胞之醫藥組合物及其用途
JP5985207B2 (ja) 2011-11-25 2016-09-06 住友化学株式会社 網膜色素上皮細胞の製造方法
CA3114895A1 (en) 2011-11-25 2013-05-30 Sumitomo Chemical Company, Limited Artificial cell aggregate comprising retinal tissue
PL2788472T3 (pl) * 2011-12-06 2019-06-28 Astellas Institute For Regenerative Medicine Sposób ukierunkowanego różnicowania z wytwarzaniem komórek śródbłonka rogówki
WO2013148377A1 (en) 2012-03-25 2013-10-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for modulating hair growth using truncated laminin-511
PT2925856T (pt) 2012-12-03 2018-06-15 Biolamina Ab Métodos de produção de células epr
SG10201802877WA (en) 2013-10-09 2018-05-30 Healios Kk Method of producing retinal pigment epithelial cell
MX387839B (es) 2014-10-31 2025-03-04 Senju Pharma Co Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea.
EP3213761B1 (en) 2014-10-31 2021-05-19 Kyoto Prefectural Public University Corporation Novel treatment of retina using laminin
US12403161B2 (en) 2018-06-29 2025-09-02 Stellular Bio, Inc. Compositions for drug delivery and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2016539641A5 (enExample)
RU2016125225A (ru) Применение ламинина в культуре клеток эндотелия роговицы
JP2014501518A5 (enExample)
WO2016083613A3 (en) Culture medium
EP4324913A3 (en) Culture media for stem cells
WO2012056110A3 (en) Cell culture material based on microbial cellulose
JP2016533322A5 (enExample)
EP3161127A4 (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
IL236878B (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
WO2011094572A3 (en) Hanging drop devices, systems and/or methods
EP4234032A3 (en) Induction medium and methods for stem cell culture and therapy
WO2015158808A3 (en) Recombinant host cell engineered to overexpress helper proteins
JP2011004745A5 (enExample)
JP2016510727A5 (enExample)
EP2543688A4 (en) Polymerization fluid, process for production thereof, transparent film made from the polymerization fluid, and transparent electrode
JP2016500260A5 (enExample)
MX2016002468A (es) Sistema y metodos para la propagacion continua y produccion en masa de hongos micorricicos arbusculares en cultivo liquido.
EP2995677A4 (en) Culture medium composition for improving regenerative capacity of stem cells, and stem cell culturing method using same
HRP20210579T1 (hr) Cisteini protutijela s kapom i bez kape, te njihova upotreba u konjugiranju protutijela s lijekom
WO2016106192A3 (en) Methods of culturing a mammalian cell
EP3511410A4 (en) MEDIUM FOR CULTIVATION OF STEM CELLS, METHOD FOR CULTURE OF STEM CELLS, PROMOTER OF STEM CELL GROWTH, AND CELL COMPOSITION AND METHOD FOR PRODUCING THE SAME
JP2012210156A5 (enExample)
EP4328299A3 (en) Cell culture media compositions for primary cells
WO2015073625A3 (en) Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors
EP3162892A4 (en) Method for culturing adhesive cells, culture vessel, and method for producing protein